Spanish scientists identify a new treatment strategy against a very aggressive subtype of breast cancer Published on 19/10/2022 HER2+ breast cancer, diagnosed in 7,000 new cases in 2022, is a very aggressive subtype of poor prognosis because most patients develop drug resistance
Immediate access to innovation in kidney cancer treatments, essential for patient survival Published on 08/03/2022 MD Anderson Madrid offers the possibility of access to clinical trials and surgery with the Da Vinci robot for patients with kidney cancer, one of the 15 most common tumors in Spain
The DIPCAN study seeks to change the way metastatic cancer is treated in Spain thanks to the integration of clinical, genomic, anatomic pathology and radiology image data from 2,000 patients Published on 22/02/2022 Participating patients will have free access to the genomic study of their tumor, both in the biopsy sample and in blood, to a full-body MRI and to digitization of anatomic pathology images
MD Anderson Madrid inaugurates their Phase I Clinical Trials Unit, one of the largest in Spain and Europe dedicated to the first phase of research Published on 03/11/2021 Advised directly from Houston, the unit will focus on research into the most promising cancer drugs in clinical development worldwide. It is estimated that more than 40 clinical studies in phase I will be investigated simultaneously
MD Anderson Madrid and El Economista join Movember to offer health advice for men over 40 Published on 14/11/2019 This year the MD Anderson Cancer Center Madrid has again joined in with the Movember movement, an initiative now over ten years old that seeks to boost men’s healthcare during November.
MD Anderson Cancer Center Madrid launches a platform to predict toxicity of chemotherapy Published on 20/09/2019 The analysis of these results, easily obtainable through a simple blood sample, allows the healthcare professional to adjust the doses or opt for other treatments that are less toxic for the patient